Resting Heart Rate and Metabolic Syndrome in Patients With Diabetes and Coronary Artery Disease in Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Preventive Cardiology

Volumn 13, Issue 3, 2010, Pages 112-116

  Rana, Jamal ^a,b   Hardison, Regina ^b   Pop Busui, Rodica ^c   Brooks, Maria ^b   Jones, Teresa ^d   Nesto, Richard ^e   Bourassa, Martial ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANGIOPLASTY; ARTICLE; BODY MASS; BYPASS SURGERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE FUNCTION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS INDICATORS; HEART RATE; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; REST; RISK FACTORS; STATISTICS AS TOPIC; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77955130278     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2010.00067.x     Document Type: Article

References (24)

1. Fox K, Borer JS, Camm AJ. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007, 50:823-830.
2. Palatini P. Heart rate: a strong predictor of mortality in subjects with coronary artery disease. Eur Heart J. 2005, 26(10):943-945.
3. Diaz A, Bourassa MG, Guertin MC. Long term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005, 26:967-974.
4. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes. 2003, 111:215-222.
5. Carnethon M, Yan L, Greenland P. Resting heart rate in middle age and diabetes development in older age. Diabetes Care. 2008, 31(2):335-339.
6. Festa A, D'Agostino R, Hales CN. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2003, 23:624-628.
7. Tomiyama H, Yamada J, Koji Y. Heart rate elevation precedes the development of metabolic syndrome in Japanese men: a prospective study. Hypertens Res. 2007, 30:417-426.
8. Grassi G, Seravalle G. Autonomic imbalance and metabolic syndrome: unravelling interactions, mechanisms and outcomes. J Hypertens. 2006, 24:47-49.
9. Gami AS, Witt BJ, Howard DE. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49:403-414.
10. Inoue T, Oshiro S, Iseki K. High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J. 2001, 65:969-973.
11. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009, 360:2503-2515.
12. Grundy SM, Cleeman JI, Daniels SR. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112:2735-2752.
13. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia. 1985, 28(suppl):615-640.
14. Min KB, Min JY, Paek D. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008, 31:584-591.
15. Watanabe K, Sekiya M, Tsuruoka T. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens. 1999, 17:1161-1168.
16. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980, 65:717-721.
17. Paolisso G, Manzella D, Rizzo MR. Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states. Clin Sci (Lond) 2000, 98(2):129-136.
18. Bellavere F, Cacciatori V, Moghetti P. Acute effect of insulin on autonomic regulation of the cardiovascular system: a study by heart rate spectral analysis. Diabet Med. 1996, 13(8):709-714.
19. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens. 1996, 9:1013-1017.
20. Grynberg A, Ziegler D, Rupp H. Sympathoadrenergic overactivity and lipid metabolism. Cardiovasc Drugs Ther. 1996, 10:223-230.
21. Grassi G, Dell'Oro R, Quarti-Trevano F. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005, 48:1359-1365.
22. Piestrzeniewicz K, Łuczak K, Lelonek M. Obesity and heart rate variability in men with myocardial infarction. Cardiol J. 2008, 15:43-49.
23. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001, 104:1477-1482.
24. Julius S, Krause L, Schork NJ. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991, 9:77-84.